224 related articles for article (PubMed ID: 12516040)
1. Complementary and alternative therapies in prostate cancer.
Oh WK; Small EJ
Semin Oncol; 2002 Dec; 29(6):575-84. PubMed ID: 12516040
[TBL] [Abstract][Full Text] [Related]
2. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
[TBL] [Abstract][Full Text] [Related]
3. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.
Hsieh TC; Wu JM
Int J Oncol; 2002 Mar; 20(3):583-8. PubMed ID: 11836572
[TBL] [Abstract][Full Text] [Related]
5. The role of PC-SPES, selenium, and vitamin E in prostate cancer.
Das P; Kaplan I
Oncology (Williston Park); 2002 Mar; 16(3):285-91; discussion 291, 295-6, 299-300. PubMed ID: 15046388
[TBL] [Abstract][Full Text] [Related]
6. PC-SPES: a herbal therapy for the treatment of hormone refractory prostate cancer.
Meyer JP; Gillatt DA
Prostate Cancer Prostatic Dis; 2002; 5(1):13-5. PubMed ID: 15195124
[TBL] [Abstract][Full Text] [Related]
7. Critical review of complementary therapies for prostate cancer.
Wilkinson S; Chodak GW
J Clin Oncol; 2003 Jun; 21(11):2199-210. PubMed ID: 12775747
[TBL] [Abstract][Full Text] [Related]
8. PC-SPES: hope or hype?
Kosty MP
J Clin Oncol; 2004 Sep; 22(18):3657-9. PubMed ID: 15289490
[No Abstract] [Full Text] [Related]
9. UsToo PC-SPES surveys: review of studies and update of previous survey results.
Porterfield H
Mol Urol; 2000; 4(3):289-91;discussion 293. PubMed ID: 11062386
[TBL] [Abstract][Full Text] [Related]
10. [PC SPES in prostatic cancer: critical review of the literature].
de la Taille A
Prog Urol; 2001 Jun; 11(3):428-32. PubMed ID: 11512453
[TBL] [Abstract][Full Text] [Related]
11. Complementary and alternative medicine (CAM) in prostate and bladder cancer.
Philippou Y; Hadjipavlou M; Khan S; Rane A
BJU Int; 2013 Dec; 112(8):1073-9. PubMed ID: 23944379
[TBL] [Abstract][Full Text] [Related]
12. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.
Bonham M; Arnold H; Montgomery B; Nelson PS
Cancer Res; 2002 Jul; 62(14):3920-4. PubMed ID: 12124319
[TBL] [Abstract][Full Text] [Related]
13. PC-SPES and prostate cancer.
Oh WK; Small EJ
Urol Clin North Am; 2002 Feb; 29(1):59-66, viii. PubMed ID: 12109356
[TBL] [Abstract][Full Text] [Related]
14. Mass spectral analysis of PC-SPES confirms the presence of diethylstilbestrol.
Guns ES; Goldenberg SL; Brown PN
Can J Urol; 2002 Dec; 9(6):1684-8; discussion 1689. PubMed ID: 12517310
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of PC-Spes2 in advanced hormone refractory prostate cancer.
Shabbir M; Love J; Montgomery B
Oncol Rep; 2008 Mar; 19(3):831-5. PubMed ID: 18288423
[TBL] [Abstract][Full Text] [Related]
16. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.
de la Taille A; Hayek OR; Burchardt M; Burchardt T; Katz AE
J Altern Complement Med; 2000 Oct; 6(5):449-51. PubMed ID: 11059508
[TBL] [Abstract][Full Text] [Related]
17. Herbal composition PC-SPES for management of prostate cancer: identification of active principles.
Sovak M; Seligson AL; Konas M; Hajduch M; Dolezal M; Machala M; Nagourney R
J Natl Cancer Inst; 2002 Sep; 94(17):1275-81. PubMed ID: 12208892
[TBL] [Abstract][Full Text] [Related]
18. [PC-SPES and ProstaSol: Chinese herbal medicine as a treatment for prostate cancer].
Jensen JB; Langkilde NC
Ugeskr Laeger; 2004 Dec; 166(50):4611-2. PubMed ID: 15633553
[No Abstract] [Full Text] [Related]
19. Contaminants of PC-SPES are not responsible for cytotoxicity in human small-cell lung carcinoma cells.
Sadava D; Winesburg J
Cancer Lett; 2005 Apr; 220(2):171-5. PubMed ID: 15766592
[TBL] [Abstract][Full Text] [Related]
20. Unconventional therapy for prostate cancer: good, bad or questionable?
Nelson PS; Montgomery B
Nat Rev Cancer; 2003 Nov; 3(11):845-58. PubMed ID: 14668815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
